B cells and antibodies in CNS demyelinating disease

被引:180
|
作者
Cross, AH [1 ]
Trotter, JL [1 ]
Lyons, JA [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
关键词
multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody;
D O I
10.1016/S0165-5728(00)00409-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [21] B Cells and Antibodies in Kawasaki Disease
    Lindquist, Michael E.
    Hicar, Mark D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [22] Occurrence of CNS demyelinating disease in patients with myasthenia gravis
    Kister, I.
    Herbert, J.
    Swerdlow, M. L.
    Bergamaschi, R.
    Piccolo, G.
    Oger, J.
    NEUROLOGY, 2007, 68 (16) : 1326 - 1327
  • [23] Phenotypic and functional features of CNS CD8+T cells mediating a demyelinating disease
    N'Diaye, Marie
    Fournier, Sylvie
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 249 - 249
  • [24] Demyelinating disease and anti-axonal antibodies
    Schwartz, R. F.
    Campbell, C.
    Muller, H.
    Kennett, R.
    Feinstein, D.
    Kaiser, C.
    Becker-Catania, S.
    Bare, D. J.
    Devries, G. H.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 145 - 145
  • [25] Anti-axonal antibodies in demyelinating disease
    Kennett, R
    Takelo, E
    Lewis, P
    Feinstein, DL
    Kaiser, C
    Sharp, A
    Becker-Catania, S
    Nelson, J
    Devries, GH
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 132 - 132
  • [26] detection of anti mog antibodies in demyelinating disorders of the central nervous system (CNS)
    Sala, A.
    Spadaro, M.
    Capobianco, M.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 687 - 687
  • [27] DETECTION OF ANTI MOG ANTIBODIES IN DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM (CNS)
    Bertolotto, Antonio
    Capobianco, Marco
    Spadaro, Michela
    Sala, Arianna
    NEUROLOGY, 2017, 88
  • [28] Human Recombinant Monoclonal Antibodies as Therapy for Demyelinating and Degenerative CNS Disorders.
    Rodriguez, Moses
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 397 - 397
  • [29] Demyelinating disease and anti-axonal antibodies
    Kaiser, C.
    Becker-Catania, S.
    Bare, D. J.
    De Vries, G. H.
    JOURNAL OF NEUROCHEMISTRY, 2006, 99 : 25 - 25
  • [30] Seroprevalence of myelin oligodendrocyte glycoprotein antibodies in unselected patients with CNS inflammatory demyelinating disease according to recent clinical attacks
    Lee, E. -J.
    Kim, S.
    Choi, L.
    Lee, S.
    Kim, H. W.
    Kim, H.
    Kim, S. K.
    Lim, Y. -M.
    Kim, K. -K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 144 - 145